Sanofi-Aventis (Suisse) SA - Multaq, comprimés pelliculés de 400 mg de dronédarone | | 59292 | | 01 | | Multaq, comprimés pelliculés de 400 mg de dronédarone | | | | C01BD07 | | Dronedarone | | 09.09.2009 | | |
| Composition | dronedaronum 400 mg ut dronedaroni hydrochloridum 426 mg, hypromellosum, maydis amylum, crospovidonum, poloxamerum 407, lactosum monohydricum 41.65 mg, silica colloidalis anhydrica, magnesii stearas, pellicule: hypromellosum, macrogolum 6000, cera carnauba, color.: E 171, pro compresso obducto. | Packungsbestandteile | Active Agent | Dose |
---|
Dronedaronum | 400 mg |
| BAG: Active Agent | Dose |
---|
Dronedaronum | 400 mg |
| Inactive agents | Dose | additional_information |
---|
Cera Carnauba | | | Crospovidonum | | | E 171 | | color. | Hypromellosum | | pellicule | Lactose Monohydrate | 41.65 mg | | Macrogol | 6000 | | Magnesii Stearas | | | Maydis Amylum | | | Poloxamer | 407 | | Pro Compresso Obducto | | | Silica Colloidalis Anhydrica | | |
| |
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
---|
001 | 60 Tablet(s) | 38.14 | 57.90 | B | SL | Yes | 002 | 100 Tablet(s) | PR | PR | B | | Yes |
|
|